Dr. Irayani Berger

Dr. Irayani Berger has held multiple roles in the pharmaceutical industry. From 2010 to 2012, they worked as the Head of Stability Studies (Quality Control) at Dragenopharm Apotheker Pueschl GmbH. In 2012, they joined Luye Pharma Group as the Head of Quality Assurance (Qualified Person), where they stayed until 2017. Currently, they are serving as the Vice President Corporate Quality at Aenova Group.

Dr. Irayani Berger holds an Executive MBA from the Technical University of Munich, which they attained from 2016 to 2018. Dr. Irayani also completed their Doctor of Human Biology - PhD degree at Ludwig-Maximilians-Universität München from 2007 to 2010. Prior to that, they received a degree in Pharmazie from Technische Universität Braunschweig from 2000 to 2006. In 2018, Dr. Berger obtained the certification of Certified Senior Project Manager - IPMA Level B from IPMA: International Project Management Association.